Close Mobile Navigation

WELCOME TO THE
KEYTRUDA
PATIENT SUPPORT
WEBSITE


GET ACCESS

To access this website, you must be a current patient being treated with KEYTRUDA in Australia and be 18 years or older.

  • The access code is supplied within the KEYTRUDA patient booklet which you can request from your healthcare professional, if you don’t have a copy.
  • Alternatively, please contact your treating healthcare professional to request the access code to access this website.

Registered users are no longer required to sign in using their registered email address and password. Please enter the access code to continue accessing this website.

The access code entered is not valid, please try again or contact your Healthcare Professional.


MSD Medical Information or to report product complaints (including adverse events): 1800 818 553

This educational website is sponsored by Merck Sharp & Dohme (Australia) Pty Ltd. Information displayed on this website is only intended for Australian residents who are 18 years or older and are currently being treated with KEYTRUDA and as such, its contents have been designed to comply with Australian laws and regulations. The information on this website is educational only and is not intended to be used for any self-diagnosis purposes nor to replace the advice of your Doctor or healthcare professional. Please consult your Doctor or healthcare professional for further information on KEYTRUDA. Use and access of this website is subject to the terms and conditions set out in our Legal Agreement and Privacy Policy.

Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
Merck Sharp & Dohme (Australia) Pty Limited. Level 1 – Building A, 26 Talavera Road, Macquarie Park NSW 2113.
AU-KEY-00559. Issued March 2024.


MANAGING YOUR TREATMENT WITH KEYTRUDA

There are some key things you should know about KEYTRUDA that may help you understand and manage your treatment.


DAY-TO-DAY WITH KEYTRUDA

Administration

KEYTRUDA is delivered as a liquid directly into a vein, usually in your hand or arm. This will happen in a hospital or clinic, with an oncologist, haematologist or nurse looking after you. The actual infusion takes about 30 minutes, but you are likely to be required to stay in the hospital or clinic for longer than this. Your oncology team will be able to advise how long you should set aside on the day you receive your infusion.

KEYTRUDA is usually administered every 3 weeks or every 6 weeks, depending on the dose you are given.

Monitoring

You will have regular tests while you are receiving treatment with KEYTRUDA to see what effects it is having on your cancer and your general health.


Effects on your day-to-day life

KEYTRUDA affects different people in different ways. You won’t know what sort of impact it will have on your day-to-day life until treatment has started.

  • Like all medicines, KEYTRUDA can cause side effects, although not everybody gets them.
  • When you get KEYTRUDA, you can have some serious side effects. These side effects can sometimes become life-threatening and can lead to death.
  • It’s important to let your healthcare team know if you have any side effects that bother you or that do not go away.
  • KEYTRUDA may affect your ability to work. On treatment days – and maybe for a day or so after – you may not be able to attend work, or may need to rest at regular periods.

Your responsibilities

You are as much a part of your treatment team as your oncologist or dietitian. Keeping your team informed of how you feel is very important.

  • Tell your doctor as soon as you experience any side effects. Your doctor will be able to advise you on the best way to manage any side effects. This may mean your symptoms resolve or do not become more serious, which can compromise your treatment.
  • Keep your appointments. If you can’t make an appointment, reschedule it as soon as possible.
  • Maintain a healthy lifestyle. Eat well, exercise appropriately, and look after your emotional health. If you don’t know what’s best for your health, ask a member of your care team for advice.
  • Tell anyone professionally involved in your healthcare that you are taking KEYTRUDA. This includes all doctors, nurses, pharmacists and dentists.
  • Consult your doctor before taking any non-prescription medicines, herbal preparations or other alternative substances. These may interfere with your KEYTRUDA treatment.



References

KEYTRUDA Australian Consumer Medicine Information www.msdinfo.com.au/keytrudacmi

KEYTRUDA Australian Approved Product Information  www.msdinfo.com.au/keytrudapi.

Cancer Council Australia. 2021. Emotions and Cancer, A guide for people with cancer, their family and friends. Available at: www.cancer.org.au/assets/pdf/emotions-and-cancer-booklet Accessed September 2023.

Cancer Council Australia. 2021. Understanding Immunotherapy, A guide for people affected by cancer. Available at: www.cancer.org.au/assets/pdf/understanding-immunotherapy-fact-sheet. Accessed September 2023.

For further information about your condition or treatment consult your healthcare professional or refer to the Consumer Medicine Information for KEYTRUDA.

AU-KEY-00465. Issued September 2023.



MSD Medical Information or to report product complaints (including adverse events): 1800 818 553

This educational website is sponsored by Merck Sharp & Dohme (Australia) Pty Ltd. Information displayed on this website is only intended for Australian residents who are 18 years or older and are currently being treated with KEYTRUDA and as such, its contents have been designed to comply with Australian laws and regulations. The information on this website is educational only and is not intended to be used for any self-diagnosis purposes nor to replace the advice of your Doctor or healthcare professional. Please consult your Doctor or healthcare professional for further information on KEYTRUDA. Use and access of this website is subject to the terms and conditions set out in our Legal Agreement and Privacy Policy.

Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
Merck Sharp & Dohme (Australia) Pty Limited. Level 1 – Building A, 26 Talavera Road, Macquarie Park NSW 2113.
AU-KEY-00559. Issued March 2024.